Product Information
EPIPEN JR 2-PAK 0.15 MG INJCTR is a brand product labeled by Viatris Specialty LLC, priced at $290.6380 per EA under NDC 49502050102. Its NADAC has been published 641 times since Nov 28, 2013.
FDA first approved this application on Dec 22, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.15 mg/.3mL
Manufacturer
Viatris Specialty LLCNDC
49502050102
Classification
Brand
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
3/19/2025
Active Ingredients
EPINEPHRINEApproval Type
New Drug (NDA)
FDA Application
NDA019430FDA Approved
12/22/1987
TE Code
AB
On Market Since
12/22/1987
Pharmacological Classes
Price Statistics
The NADAC for EPIPEN JR 2-PAK 0.15 MG INJCTR has been published 641 times since Nov 28, 2013, and over the history we have for it it has risen 98.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $290.6380 per EA |
|---|---|
| All-time high | $295.4033 (Sep 11, 2019) |
| All-time low | $146.7911 (Nov 28, 2013) |
| 52-week high | $290.6380 |
| 52-week low | $290.6380 |
| Median price | $291.4090 |
| Average price | $273.0079 |
| Largest weekly change | +14.9% (May 13, 2015) |
| Weeks tracked | 641 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
-0.3%
5Y
-0.3%
All
+98.0%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EPIPEN JR 2-PAK 0.15 MG INJCTR?
The current National Average Drug Acquisition Cost (NADAC) for EPIPEN JR 2-PAK 0.15 MG INJCTR, manufactured by Viatris Specialty LLC, is $290.6380 per EA (NDC 49502050102), effective Mar 11, 2026.
How has the price of EPIPEN JR 2-PAK 0.15 MG INJCTR changed over time?
Over the history we have for it, the NADAC for EPIPEN JR 2-PAK 0.15 MG INJCTR has risen 98.0%. It has been tracked across 641 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EPIPEN JR 2-PAK 0.15 MG INJCTR?
Since Nov 28, 2013, the NADAC for EPIPEN JR 2-PAK 0.15 MG INJCTR has ranged from a low of $146.7911 (Nov 28, 2013) to a high of $295.4033 (Sep 11, 2019), with a median of $291.4090 per EA.
Are there cheaper alternatives to EPIPEN JR 2-PAK 0.15 MG INJCTR?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPINEPHRINE 0.15 MG AUTO-INJCT, is $118.5934 per EA — about 59% below EPIPEN JR 2-PAK 0.15 MG INJCTR.
Who manufactures EPIPEN JR 2-PAK 0.15 MG INJCTR?
EPIPEN JR 2-PAK 0.15 MG INJCTR (NDC 49502050102) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.